| Application no. and date | 06748594.6 (espacenet) (Federated) (European Patent Register), 20060322 | | Patent/reg. no. and date | DK/EP 1861116, 20150916 | | Publication date | 20071205 | | Priority no. and date | US 665125 P, 20050325 | | EP pub. no. and date |
EP 1861116 20071205 | | Effective date | | | Applicant/owner | REGENERON PHARMACEUTICALS, INC., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | V220DKEP | | Inventor | DIX, Daniel, 55 Memory Trail
LaGrangeville, New York 12540, US,
FRYE, Kelly, 29 N. Ridge Road
Pomona, New York 10970, US,
KAUTZ, Susan, 3 Hall Place
Albany, New York 12210, US | | Representative | JESPER LEVIN A/S, Jægersborg Alle 93, 2820 Gentofte, DK | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61K 47/00 (2006.01) | | Title | VEGF-antagonistformuleringer | | Int. application no. | US2006010600 | | Int. publication no. | WO2006104852 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
